Encapsulation of Gold Nanorods with Porphyrins for the Potential Treatment of Cancer and Bacterial Diseases: A Critical Review
Clicks: 293
ID: 7874
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Star Article
74.8
/100
284 views
230 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Cancer and bacterial diseases have been the most incidental diseases to date. According to the World Health Report 2018, at least every family is affected by cancer around the world. In 2012, 14.1 million people were affected by cancer, and that figure is bound to increase to 21.6 million in 2030. Medicine therefore sorts out ways of treatment using conventional methods which have been proven to have many side effects. Researchers developed photothermal and photodynamic methods to treat both cancer and bacterial diseases. These methods pose fewer effects on the biological systems but still no perfect method has been synthesized. The review serves to explore porphyrin and gold nanorods to be used in the treatment of cancer and bacterial diseases: porphyrins as photosensitizers and gold nanorods as delivery agents. In addition, the review delves into ways of incorporating photothermal and photodynamic therapy aimed at producing a less toxic, more efficacious, and specific compound for the treatment.
| Reference Key |
nthabeleng2019encapsulationbioinorganic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hlapisi, Nthabeleng;Motaung, Tshwafo E.;Linganiso, Linda Z.;Oluwafemi, Oluwatobi S.;Songca, Sandile P.;Hlapisi, Nthabeleng;Motaung, Tshwafo E.;Linganiso, Linda Z.;Oluwafemi, Oluwatobi S.;Songca, Sandile P.; |
| Journal | bioinorganic chemistry and applications |
| Year | 2019 |
| DOI |
10.1155/2019/7147128
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.